SCM
AVDL

Sio Capital Management’s Avadel Pharmaceuticals AVDL Stock Holding History

Sio Capital Management’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-91,413
Closed -$960K – 50
2017
Q3 		$960K Hold
91,413
– – 0.5% 39
2017
Q2 		$1.01M Hold
91,413
– – 0.48% 49
2017
Q1 		$885K Hold
91,413
– – 0.5% 38
2016
Q4 		$950K Buy
+91,413
New +$1M 0.55% 39
2016
Q1 		– Sell
-124,017
Closed -$1.51M – 45
2015
Q4 		$1.51M Sell
124,017
-115,681
-48% -$1.8M 0.67% 33
2015
Q3 		$3.91M Sell
239,698
-80,302
-25% -$1.77M 2.68% 18
2015
Q2 		$6.78M Buy
+320,000
New +$5.74M 3.35% 5

Other funds holding AVDL

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Sio Capital Management's AVDL Position: Q4 2017 in Review

Sio Capital Management sold out of Avadel Pharmaceuticals (AVDL) in Q4 2017, closing a stake of 91,413 shares — an estimated $960K sold.

Sio Capital Management first reported a position in AVDL in Q2 2015 and held it in 7 quarters. The position peaked at $6.78M in Q2 2015. 83 funds tracked by Wall St. Rank hold AVDL as of Q4 2017.

  • Sio Capital Management reported no remaining Avadel Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Sio Capital Management sold 91,413 Avadel Pharmaceuticals shares in Q4 2017, an estimated $960K.
  • Sio Capital Management first reported a position in Avadel Pharmaceuticals in Q2 2015 and held it in 7 quarters.
  • Sio Capital Management's Avadel Pharmaceuticals position peaked at $6.78M in Q2 2015.
  • 83 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q4 2017.

Based on Sio Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.